Gregory L. Verdine sold $269k of WVE
director at Wave Life Sciences Ltd.. 20,000 shares at an average of $13.47, traded Dec 8, 2025, filed Dec 10, 2025.
Score components
- +15RoleDirector
- +13Trade size$269k at market
- 0Share of holdings soldSold 6.8% of holdings
- +15Cluster8 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -31.6%, 3m -30.4%, 6m -72.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-314738, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -12,020 | $13.09 | $157k | 283,197 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -7,980 | $14.05 | $112k | 275,217 | Dec 10, 2025 |
Related signals
Other insiders at Wave Life Sciences Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 49Moderate | WVEbuy Wave Life Sciences Ltd. | Ra Capital Management, L.p. director, owner | $55M 8,772,496 shares | +48% | |
| 8Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $500k 33,194 shares | -42% | |
| 51Moderate | Wave Life Sciences Ltd. | Paul Bolno President and CEO | $141k 10,480 shares | -4% | |
| 35Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $25k 1,883 shares | -3% | |
| 44Moderate | Wave Life Sciences Ltd. | Kyle Moran Chief Financial Officer | $48k 3,588 shares | -3% | |
| 36Weak | Wave Life Sciences Ltd. | Chandra Vargeese See Remarks | $43k 3,228 shares | -1% | |
| 1Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $150k 9,375 shares | -27% | |
| 39Weak | WVEbuy Wave Life Sciences Ltd. | GSK plc owner | $28M 1,470,000 shares | +9% | |
| 32Weak | Wave Life Sciences Ltd. | Mark Corrigan director | $217k 16,115 shares | -36% | |
| 40Moderate | Wave Life Sciences Ltd. | Chris Francis See Remarks | $6.4M 441,031 shares | -830% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.